3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
19
Prostatic Neoplasms
9
Polycystic Ovary Syndrome
7
Vitamin D Deficiency
6
Osteoporosis
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
4
Colonic Neoplasms
4
Obesity
3
Inflammation
3
Colorectal Neoplasms
3
Bone Diseases, Metabolic
3
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Gastrointestinal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Cancers
1
Interventions
Acupuncture Therapy
10
Exercise
6
Cryotherapy
6
Paclitaxel
5
Glutamine
4
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
pembrolizumab
1
nicotinamide-beta-riboside
1
glutamic acid diethyl ester
1
enfortumab vedotin
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Vitamin B 6
1
Vitamin B 12
1
Ultrasonic Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peripheral Nervous System Diseases
×
Vitamin D
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled